VedaBio

Seed / Series A

defense-other · Seed

Seed Signal Score

11/25

Team Strength

2/5

Validation Depth

2/5

Novelty

3/5

Market Timing

2/5

Capital Efficiency

2/5

www.vedabio.com

Description

CRISPR powered Diagnostics with results in minutes.

Validation Signals

yc batch

Score Rationale

VedaBio presents as a biotech diagnostics company with CRISPR-based rapid testing, but lacks clear defense domain expertise in the founding team (no named founders provided) and no visible defense-specific validation or contracts. While rapid diagnostics have potential CBR/CBRN applications, the company shows no evidence of DoD engagement, SBIR awards, or defense customer pilots—only YC affiliation—making it speculative for defense tech investment at seed stage.

Back to all companies